cimetidine has been researched along with Pituitary Diseases in 1 studies
Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.
Pituitary Diseases: Disorders involving either the ADENOHYPOPHYSIS or the NEUROHYPOPHYSIS. These diseases usually manifest as hypersecretion or hyposecretion of PITUITARY HORMONES. Neoplastic pituitary masses can also cause compression of the OPTIC CHIASM and other adjacent structures.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
García Centenera, JA | 1 |
Requejo, F | 1 |
Alba, JP | 1 |
Herrán, M | 1 |
Lucero, JL | 1 |
Vilchez, JM | 1 |
Hervás, F | 1 |
1 trial available for cimetidine and Pituitary Diseases
Article | Year |
---|---|
[H2-receptors and prolactin secretion. Effects of acute and chronic administration of cimetidine on subjects with normal and high levels of prolactin (author's transl)].
Topics: Adult; Cimetidine; Clinical Trials as Topic; Dose-Response Relationship, Drug; Guanidines; Humans; I | 1980 |